Who invested in Light Horse Therapeutics?
Light Horse Therapeutics's investors include Versant Ventures, Mubadala and AbbVie.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$62Mraised across 1 round since 2025, from 1 source
From Light Horse Therapeutics's own website: 1 on the team.
Light Horse Therapeutics's investors include Versant Ventures, Mubadala and AbbVie.
Light Horse Therapeutics has raised $62M across 1 round since 2025.
Light Horse Therapeutics's most recent round was a Series A of $62M in Jan 2025.
Its most recent round, $62M in Jan 2025, is also its largest on record.
Light Horse Therapeutics's first round on record, in Jan 2025, was backed by Versant Ventures, Mubadala and AbbVie.
Light Horse Therapeutics's latest named round is a Series A, in Jan 2025.
Light Horse Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.